Corvus Pharmaceuticals (CRVS) Stock Research

Corvus Pharmaceuticals

· CRVS

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

989.262 M

-2.04%

Today

Corvus announces initiation of Phase 1b clinical trial of soquelitinib

CRVS

4:09 PM

Over a week ago

Corvus Pharmaceuticals reports Q2 EPS (19c), consensus (17c)

CRVS

Aug 6, 4:06 PM

Corvus Pharmaceuticals reports Q1 EPS (15c), consensus (15c)

CRVS

May 7, 4:18 PM

Apple upgraded, Qualcomm downgraded: Wall Street's top analyst calls

+15

Apr 17, 9:36 AM

Corvus Pharmaceuticals initiated with bullish view at Goldman Sachs, here's why

CRVS

Apr 17, 4:42 AM

Corvus Pharmaceuticals price target raised by $1 at Oppenheimer, here's why

CRVS

Mar 13, 8:12 AM

Corvus Pharmaceuticals files automatic mixed securities shelf

CRVS

Mar 13, 8:03 AM

Corvus Pharmaceuticals reports Q4 EPS (15c), consensus (13c)

CRVS

Mar 12, 4:04 PM

Corvus Pharmaceuticals options imply 7.9% move in share price post-earnings

CRVS

Mar 12, 3:43 PM

Corvus Pharmaceuticals options imply 5.5% move in share price post-earnings

CRVS

Mar 4, 3:43 PM

Corvus Pharmaceuticals price target raised by $10 at Mizuho, here's why

CRVS

Jan 29, 6:45 AM

Mizuho biotech analysts hold an analyst/industry conference call

Jan 23, 11:38 AM

Corvus Pharmaceuticals price target raised by $29 at Jefferies, here's why

CRVS

Jan 22, 12:28 PM

Corvus Pharmaceuticals 7.9M share Secondary priced at $21.15

CRVS

Jan 22, 8:38 AM

Corvus Pharmaceuticals price target raised by $17 at Oppenheimer, here's why

CRVS

Jan 21, 8:48 AM

Closing Bell Movers: Netflix down 5% after soft guidance

Jan 20, 7:27 PM

What You Missed On Wall Street On Tuesday

+24

Jan 20, 4:14 PM

Corvus Pharmaceuticals announces $150M common stock offering

CRVS

Jan 20, 4:08 PM

Corvus Pharmaceuticals price target raised by $12 at Barclays, here's why

CRVS

Jan 20, 3:28 PM

Corvus Pharmaceuticals price target raised by $7 at Mizuho, here's why

CRVS

Jan 20, 12:33 PM

Midday Fly By: Netflix and Warner amend deal, GSK to acquire Rapt

+24

Jan 20, 12:02 PM

Corvus Pharmaceuticals price target raised by $16 at H.C. Wainwright, here's why

CRVS

Jan 20, 11:00 AM

Corvus announces results from cohort 4 of Phase 1 trial of soquelitinib

CRVS

Jan 20, 7:06 AM

Charts